In This Section
Developing new drugs for respiratory diseases – how can clinical imaging of the lungs help?
Location:
GlaxoSmithKlineStevenage, Herts
United Kingdom
Event Details:
The meeting will review the state-of-the-art in respiratory imaging as applied to drug discovery and development. At present there is little coordination of clinical imaging of the lungs with regard to its applications, strengths and weaknesses, best practice or key parameters. The focus will be on how imaging can be used to benefit all aspects of the drug discovery and development phases and which modalities may suit some aspects, but not others. The meeting will explore which respiratory drug development needs can be satisfied by current imaging modalities – and which techniques require further development or research to become a reality? Outcomes By bringing clinical imaging groups together, it may be possible to recognise the opportunities in emerging imaging methods and apply these to areas of unmet need for the pharmaceutical industry. The aim is to define how different imaging methods may provide additive value in decision-making for respiratory drug developers.
Credits Available:
CE Credit
For More Information:
Academy of Pharmaceutical Sciences of Great Britain